Today: 16 July 2026
Applied Materials, Micron strike AI memory deal as $5 billion EPIC Center nears opening

Applied Materials, Micron strike AI memory deal as $5 billion EPIC Center nears opening

SANTA CLARA, California, March 10, 2026, 07:27 PDT

Applied Materials on Tuesday announced a partnership with Micron Technology aimed at building out next-gen memory for AI systems at its EPIC research hub in Silicon Valley. The move marks another step by the chip-equipment giant into segments boosted by artificial intelligence demand. Shares of Applied climbed roughly 1.9% in early U.S. trading; Micron was up 4.3%.

Why does it matter? AI servers are soaking up more memory chips, and that’s turning up the pressure on customers to buy chipmaking gear and packaging. Last month, Applied said DRAM had become its fastest-growing segment in 2026. Back in December, Reuters flagged that memory shortages were hitting the market as tech companies chased down supply.

High-bandwidth memory, or HBM, refers to stacked DRAM that sits next to AI processors, pushing data at high speed. Applied said it’s teaming up with the other company on DRAM, HBM, and NAND flash — a storage memory variant — as well as advanced packaging to bring chips and memory closer together inside a single module. The work stretches across sites in California and Boise, Idaho.

Chief Executive Gary Dickerson described the relationship between Applied Materials and Micron as a “long-standing partnership” focused on developing higher-performance, more energy-efficient memory chips. Micron’s Sanjay Mehrotra, the company’s CEO, said memory and storage serve as “essential enablers of AI,” adding the collaboration establishes a “lab-to-fab pipeline” in the U.S. Investing.com

The partnership hands Applied a key ally as the EPIC Center nears its debut this year. Back in 2023, Reuters said the project’s early blueprint called for up to $4 billion in spending and aimed to shave almost a third off the lag between research and manufacturing. Applied’s latest figure? The site now stands as a $5 billion investment in the U.S.

Micron isn’t waiting around. Back in June, the company announced plans to ramp up its U.S. spending to $200 billion. That package covers a new cutting-edge memory fab in Boise, plus $50 billion earmarked for R&D. The goal: get 40% of its DRAM output coming from U.S. soil.

The entire memory sector has stayed under pressure. Back in December, Reuters noted that prices in certain memory segments had already more than doubled since February 2025. Samsung Electronics, for its part, said in February that robust demand for memory chips looks set to last through 2027.

After Applied released its February outlook, Morningstar’s William Kerwin called AI infrastructure demand “immense” while noting that supply was “scarce.” That update didn’t just lift Applied—the news sent Lam Research and KLA shares climbing, too. Reuters

But there’s risk in the move. Just last month, Applied settled U.S. charges over illegal exports to China’s SMIC, agreeing to pay $252 million. The company has also warned that tougher U.S. restrictions could shave roughly $600 million from its fiscal 2026 revenue, though a rebound in memory demand should soften some of that blow.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • AtaiBeckley (NASDAQ: ATAI) Soars 31% After Lilly $3.8B Buyout Bid
    July 16, 2026, 10:45 AM EDT. Shares of AtaiBeckley shot up 31% to $7.04 after Eli Lilly launched a $6.75-a-share cash bid, putting the deal value at up to $3.8 billion. Traders pushed the price $0.29 above the offer, betting on the $2.50 per share CVR tied to drug pipeline goals. About 80% of the CVR hinges on VLS-01, now in Phase 2b as a psychedelic treatment, with another 20% tied to BPL-003, which has FDA breakthrough status. The sale is expected to close in Q3, if it clears shareholder and regulatory hurdles. The market is treating most of the current price as cash and leaving some room for the CVR milestones, which still need regulatory and DEA signoffs.
AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets
Previous Story

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets

Gold Price Today Falls as Dollar Rises, but Fed and Oil Shock Keep Bullion in Play
Next Story

Gold Price Today Falls as Dollar Rises, but Fed and Oil Shock Keep Bullion in Play

Go toTop